Chongqing Peg-bio Biopharm Co., Ltd.

This early-stage trial tested a new drug called PN20 in 24 adults with lymphoma or solid tumors who had low platelets from chemotherapy. The goal was to see if a single shot before chemo is safe and could help prevent dangerously low platelet counts. Researchers monitored patient…

This early-stage study tested the safety of a new drug called FT1 in 60 healthy adults aged 18 to 45. Participants received one or more injections of FT1 or a placebo to see if it causes any side effects. The study also looked at how the drug moves through the body and whether it…